Gaffin is an infectious disease physician in New Jersey. Recently, a former patient contacted me about his wife. “She had a recent stroke which has caused cognitive decline along with slow-growing ...

The use of SGLT2 inhibitors was not associated with a clear increase in overall UTI risk among patients with RA and diabetes.

Patients older than 65 years who have urinary tract infections (UTIs) are at increased risk for sepsis and death within 60 days from UTI if not treated with immediate antibiotic therapy. Those older ...

Urinary tract infections (UTIs) are common in adults 65 and older, mainly due to age-related factors like malnutrition, poor bladder control, and uncontrolled diabetes. Symptoms in older adults may ...

(HealthDay News) — In a case vignette published in the New England Journal of Medicine, recommendations are presented for management of recurrent acute febrile urinary tract infections in older men.

Can presepsin improve risk stratification in severe UTI? This study shows it outperforms standard biomarkers for mortality prediction. Read more.

The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused by ...

Patients with diabetes, obesity, rheumatoid arthritis, or coronary artery disease have a higher risk of UTIs post-spinal fusion for deformities. The study focused on posterior fusion procedures, ...

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...

Please provide your email address to receive an email when new articles are posted on . Antibiotic use in asymptomatic bacteriuria (ASB) is a commonly encountered issue for a stewardship pharmacist ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is “first-in-its-class”, which means it uses a unique mechanism to treat UTIs, ...